Unknown

Dataset Information

0

Interaction of microtubule depolymerizing agent indanocine with different human ?? tubulin isotypes.


ABSTRACT: Tubulin isotypes are known to regulate the stability and dynamics of microtubules, and are also involved in the development of resistance against microtubule-targeted cancer drugs. Indanocine, a potent microtubule depolymerizing agent, is highly active against multidrug-resistant (MDR) cancer cells without affecting normal cells. It is known to disrupt microtubule dynamics in cells and induce apoptotic cell death. Indanocine is reported to bind to tubulin at the colchicine site i.e. at the interface of ?? tubulin heterodimer. However, it's precise binding mode, involved molecular interactions and the binding affinities with different ??-tubulin isotypes present in MDR cells are not well understood. Here, the binding affinities of human ??-tubulin isotypes with indanocine were examined, employing the molecular modeling approach i.e. docking, molecular dynamics simulation and binding energy calculations. Multiple sequence analysis suggests that the amino acid sequences are different in the indanocine binding pockets of ?I, ?IIa, ?III and ?VI isotypes. However, such differences are not observed in the amino acid sequences of ?IVa, ?IVb, and ?V tubulin isotypes at indanocine binding pockets. Docking and molecular dynamics simulation results show that indanocine prefers the interface binding pocket of ??IIa, ??III, ??IVb, ??V, and ??VI tubulin isotypes; whereas it is expelled from the interface binding pocket of ??IVa and ??I-tubulin isotypes. Further, binding free energy calculations show that ??VI has the highest binding affinity and ??I has the lowest binding affinity for indanocine among all ?-tubulin isotypes. The binding free energy decreases in the order of ??VI > ??IVb > ??IIa > ??III > ??V > ??IVa > ??I. Thus, our study provides a significant understanding of involved molecular interactions of indanocine with tubulin isotypes, which may help to design potent indanocine analogues for specific tubulin isotypes in MDR cells in future.

SUBMITTER: Kumbhar BV 

PROVIDER: S-EPMC5870988 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Interaction of microtubule depolymerizing agent indanocine with different human αβ tubulin isotypes.

Kumbhar Bajarang Vasant BV   Panda Dulal D   Kunwar Ambarish A  

PloS one 20180327 3


Tubulin isotypes are known to regulate the stability and dynamics of microtubules, and are also involved in the development of resistance against microtubule-targeted cancer drugs. Indanocine, a potent microtubule depolymerizing agent, is highly active against multidrug-resistant (MDR) cancer cells without affecting normal cells. It is known to disrupt microtubule dynamics in cells and induce apoptotic cell death. Indanocine is reported to bind to tubulin at the colchicine site i.e. at the inter  ...[more]

Similar Datasets

| S-EPMC10005519 | biostudies-literature
| S-EPMC6362463 | biostudies-literature
| S-EPMC10505170 | biostudies-literature
| S-EPMC4117587 | biostudies-literature
| S-EPMC5818492 | biostudies-literature
| S-EPMC3286304 | biostudies-literature
| S-EPMC3382179 | biostudies-literature
| S-EPMC2257898 | biostudies-literature
| S-EPMC3820024 | biostudies-literature
| S-EPMC3158586 | biostudies-literature